RVTY Revvity, Inc. Expected net earnings per share growth this year
Revvity, Inc. (RVTY) leverages manufacturing capacities in Europe and the US to supply equipment to global pharmaceutical companies. The company maintains its scientific leadership through the implementation of AI screening and genomic analysis. The annual EPS trend, where the current status is 7.20, clearly demonstrates the business's resilience to geopolitical risks and data exchange restrictions with China.
Comprehensive metric breakdowns and analytics for Revvity, Inc. (RVTY)
- current quotes and average value forecast:
- market capitalization data:
- shareholders' equity book value data:
- debt and liquidity details:
- net income and valuation multiples indicators:
RVTY - Net Income|Expected Net Income Revvity, Inc.|RVTY - P/E Multiple|Market Cap to Projected Earnings Revvity Corp|RVTY - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Revvity Corp|RVTY - Operating profit EBITDA|Net earnings per share for the last 12 months Revvity|RVTY - Net earnings per share for the last 12 months|Year-over-year net earnings per share change for the last twelve months revvity.com|RVTY - Earnings per share growth in current year|Expected earnings per share trend next year Revvity, Inc.
Fundamental valuation:RVTY - Revvity Inc
This indicator measures the year-over-year dynamics of net earnings per share, allowing for an assessment of capital generation efficiency relative to inflationary risks. By analyzing the annual EPS growth rate, investors determine the asset's value potential, which for Revvity, Inc. (RVTY) is supported by a steady cash flow from the sale of laboratory systems and consumables.
Key competitors
A - Expected net earnings per share growth this year|Earnings per share growth in current year Quest|Illumina Platform (ILMN) - Expected net earnings per share growth this year|Earnings per share growth in current year Exact Sciences (EXAS)|BIO (bio-rad.com) - Earnings per share increase in current year|Earnings growth in current year NNNN (Anbio)|Sotera Health Corp (SHC) - Earnings per share growth rate in current year|QDEL: Net earnings per share growth this year|OPK: Earnings per share growth in current year|CDNA (caredx.com) - Net earnings per share growth this year|MRVI (maravai.com) - Earnings per share growth in current year|FLGT (Fulgent Genetics) - Earnings growth in current year|Standard BioTools Inc (LAB) - Expected net earnings per share growth this year|Net earnings per share growth this year CTKB (Cytek Bio)|Net earnings per one share growth for the current year OSUR|Exagen - Net earnings per share growth this year|mdxhealth.com (MDXH) - Earnings per share growth rate in current year|LUCD: Net earnings per share growth this year|Earnings per share increase in current year PRE (Prenetics Global)|IMDX: Earnings growth in current year|TRIB - Expected net earnings per share growth this year|Earnings per share growth in current year ProPhase Labs, Inc.|Earnings per share growth this year AIMD (ainos.com)|Earnings growth in current year CODX|Net earnings per share growth this year Heart Test Laboratories, Inc. HSCS|Biomerica, Inc - Net earnings per share growth this year|Expected net earnings per share growth this year Cardio Diagnostics Holdings Inc. (CDIO)|ONCO - Earnings per share growth in current year|Earnings per share increase in current year VRAX (viraxbiolabs.com)|BJDX (Bluejay Diagnostics, Inc.) - Net earnings per share growth this year|AWH (Aspira Women's Health, Inc.) - Earnings per share growth in current year|Net earnings per share growth this year AXDX|CNTG (CENTOGENE N.V.) - Net earnings per one share growth for the current year|Net earnings per share growth this year ENZ (Enzo Biochem, Inc.)|FRES - Earnings per share growth rate in current year|Earnings per share growth in current year Genetic Technologies Limited GENE|ME - Net earnings per share growth this year|Psychemedics Corp - Earnings growth in current year
